Recent Press Releases http://www.lsoncology.com Hyperion, Inc. Light Sciences Oncology Elects Dennis Langer, M.D., J.D. to its Board of Directors http://www.lsoncology.com/press_releases/release/pr_1305082838 Light Sciences Oncology, Inc. (LSO) today announced the election of Dennis Langer, M.D., J.D. to the... Wed, 31 Dec 1969 16:33:31 -0800 Light Sciences Oncology Wins Therapeutic Discovery Grants Totaling $488,958 from the U.S. Government for Development of Aptocine in Liver Cancer and BPH http://www.lsoncology.com/press_releases/release/pr_1288725215 Light Sciences Oncology, Inc. (LSO) today announced that it has received two grants totaling $244,479... Wed, 31 Dec 1969 16:33:30 -0800 Light Sciences Oncology Elects Mitchell Hymowitz, Founder of CFO Services LLC, to Its Board of Directors http://www.lsoncology.com/press_releases/release/pr_1287243157 Light Sciences Oncology, Inc. (LSO) today announced the election of Mitchell Hymowitz, the Founder and... Wed, 31 Dec 1969 16:33:30 -0800 Light Sciences Oncology Meets a Major Milestone in Aptocine Development with Target Enrollment in Phase 3 MCRC Trial http://www.lsoncology.com/press_releases/release/pr_1267120840 Light Sciences Oncology, Inc. (LSO) today announced the achievement of a major milestone in its late-stage... Wed, 31 Dec 1969 16:33:30 -0800 Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors http://www.lsoncology.com/press_releases/release/pr_1258750414 Light Sciences Oncology, Inc. (LSO) today announced the election of Akbar Seddigh, Chairman of the Board,... Wed, 31 Dec 1969 16:33:29 -0800 Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine™ for Prostate Conditions with Start-Up of Phase 2 BPH Trial http://www.lsoncology.com/press_releases/release/pr_1250534203 Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2... Wed, 31 Dec 1969 16:33:29 -0800 First Pediatric Patient Treated with Aptocine™, a Novel Light-Activated Drug, in Neurofibromatosis Study http://www.lsoncology.com/press_releases/release/pr_1250033310 Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patient in an investigator-sponsored... Wed, 31 Dec 1969 16:33:29 -0800 Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine™, a Novel Light-Activated Drug Therapy for Cancer http://www.lsoncology.com/press_releases/release/pr_1242437864 Light Sciences Oncology, Inc. (LSO) today announced that a new preclinical study has yielded evidence... Wed, 31 Dec 1969 16:33:29 -0800 Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors http://www.lsoncology.com/press_releases/release/pr_1233017267 Light Sciences Oncology, Inc. (LSO) today announced the election of former Commissioner of the FDA, Frank... Wed, 31 Dec 1969 16:33:29 -0800 Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma http://www.lsoncology.com/press_releases/release/pr_1227575292 Light Sciences Oncology, Inc. (LSO) today announced the completion of enrollment in a global Phase 3... Wed, 31 Dec 1969 16:33:28 -0800 Light Sciences Oncology Raises $40.1 Million in Series C Financing http://www.lsoncology.com/press_releases/release/pr_1216137530 Light Sciences Oncology, Inc. (LSO), a privately held company developing Light Infusion Therapy™ (Litx™)... Wed, 31 Dec 1969 16:33:28 -0800 Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate http://www.lsoncology.com/press_releases/release/pr_1215442249 Light Sciences Oncology Inc. (LSO) today announced that it has begun treatment of patients with benign... Wed, 31 Dec 1969 16:33:28 -0800 Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors http://www.lsoncology.com/press_releases/release/pr_1210894053 Light Sciences Oncology Inc. (LSO) today announced the appointment of David P. Holveck to its Board of... Wed, 31 Dec 1969 16:33:28 -0800 Light Sciences Oncology Initiates Phase III Trial of Its Light Infusion Therapy (Litx™) in Patients with Metastatic Colorectal Cancer http://www.lsoncology.com/press_releases/release/pr_1206666756 Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patient in its Phase III... Wed, 31 Dec 1969 16:33:27 -0800 Light Sciences Oncology Completes $30 Million Series B Private Financing http://www.lsoncology.com/press_releases/release/pr_1206666688 Light Sciences Oncology, Inc. (LSO) today announced the closing of its latest round of funding, $30 million... Wed, 31 Dec 1969 16:33:27 -0800 Light Sciences Oncology Initiates Phase II Trial of Litx™ Therapy in Patients with Glioma http://www.lsoncology.com/press_releases/release/pr_1206666622 Light Sciences Oncology today announced the treatment of the first patient in its Phase II trial for... Wed, 31 Dec 1969 16:33:27 -0800 Light Sciences Oncology Receives Special Protocol Assessment for Pivotal Phase III Trial of Litx™ Therapy in Metastatic Colorectal Cancer http://www.lsoncology.com/press_releases/release/pr_1206666556 Light Sciences Oncology today announced that it has reached an agreement with the U.S. Food and Drug... Wed, 31 Dec 1969 16:33:27 -0800 Light Sciences Oncology Purchases the Assets of its Former Parent Company Light Sciences LLC in Equity Transaction http://www.lsoncology.com/press_releases/release/pr_1206666481 Light Sciences Oncology (LSO) today announced a major initiative to strengthen its intellectual property... Wed, 31 Dec 1969 16:33:27 -0800 Light Sciences Oncology Completes Second Closing in $67 Million Financing for Late Stage Development of Litx™ and Announces Additional Directors http://www.lsoncology.com/press_releases/release/pr_1206666394 Light Sciences Oncology, Inc., a privately held company focused on the development of Light Infusion... Wed, 31 Dec 1969 16:33:25 -0800 Light Sciences Oncology Completes $35 Million Financing for Late Stage Development of Litx™ http://www.lsoncology.com/press_releases/release/pr_1206666314 Light Sciences Oncology, Inc., a privately held company focused on the development of Light Infusion... Wed, 31 Dec 1969 16:33:25 -0800 Light Sciences Oncology Announces Progress in Liver Cancer Trials http://www.lsoncology.com/press_releases/release/pr_1206666223 Light Sciences Oncology announced today that preliminary Phase 2 clinical study results using the Light... Wed, 31 Dec 1969 16:33:25 -0800